*Stock Score changes are based on previous closing prices
Financhill
Back

PTC Therapeutics Quote, Financials, Valuation and Earnings

Buy
55

PTCT
PTC Therapeutics

Last Price:
41.85
Seasonality Move:
12.84%

7 Day Trial

ALL ACCESS PASS

$ 7

PTC Therapeutics Price Quote

$41.85

PTC Therapeutics Key Stats

Buy
55
PTC Therapeutics (PTCT) is a Buy

Day range:
$40.00 - $42.34
52-week range:
$25.01 - $45.80
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
5.20
P/B ratio:
0%

Volume:
512.5K
Avg. volume:
987.9K
1-year change:
-4.36%
Market cap:
$3B
Revenue:
$538.6M
EPS:
$-7.38

How Much Does PTC Therapeutics Make?

Is PTC Therapeutics Growing As A Company?

  • What Is PTC Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.26%
  • What Is PTC Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

PTC Therapeutics Stock Price Performance

  • Did PTC Therapeutics Stock Go Up Last Month?
    PTC Therapeutics share price went up by 43.91% last month
  • Did PTCT's Share Price Rise Over The Last Year?
    PTCT share price fell by -4.36% over the past 1 year

What Is PTC Therapeutics 52-Week High & Low?

PTC Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy PTC Therapeutics?

  • How Much Debt Does PTC Therapeutics Have?
    Total long term debt quarterly is $431.9M
  • How Much Cash Does PTC Therapeutics Have?
    Cash and short term investments quarterly total is $587.8M
  • What Is PTC Therapeutics’s Book Value Per Share?
    Book value per share is -1.27

Is PTC Therapeutics Cash Flow Positive?

  • What Is PTCT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$248.6M
  • What Is PTC Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $12.5M
  • What Is PTC Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $238.1M

PTC Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    PTCT return on invested capital is -98.13%
  • What Is PTC Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -26.32%
  • What Is PTCT Return On Equity?
    ROE is a measure of profitability and is -516.88%

PTC Therapeutics Earnings Date & Stock Price

PTC Therapeutics Competitors

  • Who Are PTC Therapeutics's Competitors?
    Below is a list of companies who compete with PTC Therapeutics or are related in some way:
    • Alector Inc (ALEC)
    • Axsome Therapeutics Inc (AXSM)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Reata Pharmaceuticals Inc (RETA)

PTC Therapeutics Dividend Yield

Data Unavailable

PTC Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -7.36%
Revenue: 26.11% 1.25%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 5
Sell Recommendations: 0
Price Target: 49.10
Upside from Last Price: 17.32%

Major Shareholders

  • How many PTCT shares are owned by institutional investors?
    134.3M PTCT shares are owned by institutional investors
  • How many PTCT shares are owned by insiders?
    768.7K PTCT shares are owned by insiders